Morgan Stanley Maintains Equal-Weight on Teradyne, Raises Price Target to $397

Benzinga Newsdesk www.benzinga.com Positive 69.3%

Neg 0% Neu 0% Pos 69.3%

Morgan Stanley analyst Joseph Moore maintains Teradyne (NASDAQ:TER) with a Equal-Weight and raises the price target from $387 to $397.